Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

For reduced risk of chronic disease and a better chance at a longer life, midlife weight loss may be helpful, a new study ...

New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult ...

and lifestyle changes Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. An estimated 32 million people in the United States have COPD.

A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

TPU scientists as part of an international scientific collaboration analyzed the global need for medical care for patients ...

Emergency crews pulled nine adults from a sinking sailboat in the choppy waters of the San Francisco bay. Dr. Daniel Ngui, BSc, (P.T.), MD, CFPC, FCFP, Family Physician, discusses What is Chronic ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil ...